Drawing based on the label description. No photo yet.
“80 mg tablets: beige, oval and biconvex tablet marked with "AZ 80" on one side and plain on the reverse”
AZ 80 pill
Pill with imprint AZ 80 is brown, oval, 15 mm and has been identified as Osimertinib 80 mg. It is used for lung cancer. It is supplied by Astrazeneca Pharmaceuticals LP.
Osimertinib 80 mg
- Imprint
- AZ 80
- Strength
- 80 mg
- Used for
- Lung cancer
- Color
- Brown
- Shape
- Oval
- Size
- 15 mm
- Score
- No score line
- Form
- Tablet, film coated
- Manufacturer
- Astrazeneca Pharmaceuticals LP
- Drug class
- Cancer medicine (kinase inhibitor)
- NDC
- 0310-1350, 0310-1350-30, 0310-1350-95, 0310-1350-99, 0310-1251, 0310-1251-30
Source: the official drug label on DailyMed (US National Library of Medicine). Last checked .
Report a mistake
What is Osimertinib used for?
Osimertinib is used for lung cancer.
- Medicine type
- Cancer medicine (kinase inhibitor)
Official uses from the US prescribing label
Adjuvant Treatment of EGFR Mutation-Positive Non-Small Cell Lung Cancer (NSCLC)
TAGRISSO is indicated as adjuvant therapy after tumor resection in adult patients with non-small cell lung cancer (NSCLC) whose tumors have epidermal growth factor receptor (EGFR) exon 19 deletions or exon 21 L858R mutations, as detected by an FDA-approved test.
Locally Advanced, Unresectable (Stage III) EGFR Mutation-Positive NSCLC
TAGRISSO is indicated for the treatment of adult patients with locally advanced, unresectable (stage III) NSCLC whose disease has not progressed during or following concurrent or sequential platinum-based chemoradiation therapy and whose tumors have EGFR exon 19 deletions or exon 21 L858R mutations, as detected by an FDA-approved test.
First-line Treatment of EGFR Mutation-Positive Metastatic NSCLC
TAGRISSO is indicated for the first-line treatment of adult patients with metastatic NSCLC whose tumors have EGFR exon 19 deletions or exon 21 L858R mutations, as detected by an FDA-approved test.
First-line Treatment of EGFR Mutation-Positive Locally Advanced or Metastatic NSCLC
TAGRISSO in combination with pemetrexed and platinum-based chemotherapy is indicated for the first-line treatment of adult patients with locally advanced or metastatic NSCLC whose tumors have EGFR exon 19 deletions or exon 21 L858R mutations, as detected by an FDA-approved test.
Previously Treated EGFR T790M Mutation-Positive Metastatic NSCLC
TAGRISSO is indicated for the treatment of adult patients with metastatic EGFR T790M mutation-positive NSCLC, as detected by an FDA-approved test, whose disease has progressed on or after EGFR tyrosine kinase inhibitor (TKI) therapy.
From the FDA-approved label on DailyMed (published Sep 25, 2026).
Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.
Is this your pill? Check every detail
- One side shows AZ 80 and the other side is plain.
- It is brown, oval, 15 mm.
- Its score line and coating match the details on this page.
- It came from a pharmacy package that names the same drug.
Sold under the brand name Tagrisso.
Ingredients
Active: Osimertinib
Inactive: Mannitol, Microcrystalline Cellulose, Sodium Stearyl Fumarate, Polyvinyl Alcohol, Unspecified, Titanium Dioxide, Polyethylene Glycol 3350, Talc, Ferric Oxide Yellow, Ferric Oxide Red, Ferrosoferric Oxide, Low-Substituted Hydroxypropyl Cellulose, Unspecified
Other pills with imprint AZ 80
Same imprint, different listing. Check the color, size and maker against your pill.
Pills that look similar but are different drugs
Same color and shape, different medicine. This is why the imprint matters.
-
AN 840
Valsartan 320 mg
Brown, oval, 16 mm
Used for high blood pressure and heart failure
- 562 Verapamil Hydrochloride 180 mg Brown, oval, 15 mm Used for high blood pressure and atrial fibrillation (irregular heartbeat)
- 200 Progesterone 200 mg Brown, oval, 14 mm Used for female infertility and missed periods
- M 75 Carbidopa, Levodopa and Entacapone 37.5 mg / 150 mg / 200 mg Brown, oval, 14 mm Used for Parkinson's disease
- M 74 Carbidopa, Levodopa and Entacapone 31.25 mg / 125 mg / 200 mg Brown, oval, 14 mm Used for Parkinson's disease
- M 73 Carbidopa, Levodopa and Entacapone 25 mg / 100 mg / 200 mg Brown, oval, 16 mm Used for Parkinson's disease